News From Day 4

The importance of considering the psychosocial and emotional impacts suffered by patients with diseases causing vision loss and the relationship between patient satisfaction with care and treatment adherence/persistence were topics addressed by a series of speakers from the United Kingdom in the Sunday afternoon symposium “Patient Well-Being: Time to Take...

Speakers in a Sunday morning symposium session presented their research investigating the spatial distribution of retinal biomarkers and discussed how the information provides insights about the etiology and clinical features of age-related macular degeneration (AMD) and diabetic eye disease. Leading off the session, Dr Christine A Curcio (United States) described...

Discussing the impact of genetic factors on AMD characteristics and natural history, Steffen Schmitz-Valckenberg (Germany) concluded that according to current knowledge, genetics appears to have a more relevant association with the initial manifestation of AMD and in the early course of the disease as compared to later stages where unspecific...

Attendees at the EURETINA General Assembly meeting on Sunday morning heard that Dr Anat Loewenstein (Israel) was elected as President Elect of the society by unanimous decision of the EURETINA Board. Also during the meeting, Dr Martin S Zinkernagel (Switzerland) was confirmed as the new General Secretary of EURETINA, Dr...

Delegates attending Saturday afternoon’s Speakers’ Corner session on imaging heard colleagues describe interesting cases and findings from prospective and retrospective clinical studies evaluating the performance of different imaging platforms for characterising known and recently described retinal features associated with common and rare diseases.   Speakers’ Corner, a popular feature of...

A study detailing the pros and cons of using silicone oil as a long-term tamponade agent after complex retinal surgery was the winner of the inaugural August Deutman prize for the best e-Poster. “We know that silicone oil is a widely used tamponade agent in complex retinal surgery, but it...

Delegates filling the Auditorium on Saturday morning for the RETINAWS video course were rewarded with a valuable learning experience as top surgeons from around the world presented and discussed video excerpts showcasing complex vitreoretinal surgery, rare situations, and unique surgical techniques. The session started, however, with course director Dr Kourous...

The PULSAR trial in wet age-related macular degeneration demonstrated that aflibercept 8 mg administered every 12 or 16 weeks is noninferior in vision gains compared with aflibercept 2 mg every 8 weeks. The 60-week and 96-week outcomes of the trial were presented by Paolo Lanzetta MD, who was designated winner...

Everybody loves a good detective mystery and retinal specialists are no exception.  At the Medical Retina Mystery Cases session, the assembled audience was presented with a wide variety of puzzling case studies which highlighted the complex process of arriving at a correct diagnosis. Opening the session, Srinivas Sadda MD presented...

If current trends continue, one out of every two people on the planet will be myopic by the year 2050. Even more worryingly, a significant proportion of these will be highly myopic with all the associated problems that entails in terms of ocular morbidity, disease and vision loss, according to...

Prof. Ramin Tadayoni, the incoming President of EURETINA, discusses the challenges and opportunities facing the Society over the next few years To what do you attribute the phenomenal growth of EURETINA in recent years? Ramin Tadayoni: EURETINA is still quite a young Society and a lot has been achieved in...